Compounds > catechin

catechin and Kahler Disease

catechin has been researched along with Kahler Disease in 18 studies

Research

Studies (18)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	7 (38.89)	29.6817
2010's	7 (38.89)	24.3611
2020's	4 (22.22)	2.80

Authors

Authors	Studies
He, W; Qiu, X; Wu, X	1
Feng, Y; Huang, W; Li, C; Li, X; Shang, L; Wang, W; Wang, X; Wu, X; Xu, L; Yao, Y; Ying, P; Zhang, M; Zhang, Q	1
Bae, J; Fujimura, Y; Kumazoe, M; Park, SJ; Tachibana, H	1
Bae, J; Fujimura, Y; Hidaka, S; Kumazoe, M; Tachibana, H; Takeuchi, C	1
Fujimura, Y; Hiroi, S; Kumazoe, M; Miyakawa, J; Murata, M; Suemasu, Y; Tachibana, H; Takahashi, T; Tanaka, H; Tanimoto, Y; Yamanouchi, M; Yoshitomi, R	1
Hui, LM; Luo, JM; Zhou, CG	1
Gordon, MW; Li, Y; Mazumder, PB; Ramos, KS; Xu-Monette, ZY; Yan, F; Young, KH; Zhong, X; Zou, D	1
Fujimura, Y; Huang, Y; Kay, NE; Kim, YH; Kumazoe, M; Lesnick, C; Miura, D; Shanafelt, TD; Suzuki, T; Tachibana, H; Tsukamoto, S; Ueda, N; Yamada, S; Yamashita, S	1
Ding, Y; Gu, J; Huang, B; Li, J; Wang, Q; Zeng, L; Zhao, Y; Zheng, D	1
Goto, Y; Hirotsu, K; Huang, Y; Kim, Y; Kumazoe, M; Suda, T; Sugihara, K; Suzuki, T; Tachibana, H; Tsukamoto, S; Tsurudome, Y; Yamada, K; Yamashita, S	1
Choi, HI; Chung, KJ; Kim, HJ; Lee, DS; Lee, IK; Lee, TH; Park, BJ; Ren, L; Yang, HY; Yang, U	1
Huang, Y; Kim, Y; Kumazoe, M; Suemasu, Y; Sugihara, K; Suzuki, T; Tachibana, H; Tsukamoto, S; Tsurudome, Y; Ueda, N; Yamada, K; Yamashita, S	1
Asosingh, K; Menu, E; Van Camp, B; Van Riet, I; Van Valckenborgh, E; Vande Broek, I; Vanderkerken, K	1
Furusawa, M; Kashimata, M; Nagayama, M; Takeuchi, H; Tanaka, T; Tsuchiya, H	1
Baatout, S; Derradji, H; Jacquet, P; Mergeay, M; Michaux, A; Ooms, D	1
Ikeda, Y; Ito, K; Kizaki, M; Nakazato, T	1
Anderson, KC; Batchu, RB; Bertheau, RC; Fulciniti, M; Goyal, RK; Koley, H; Munshi, NC; Munshi, V; Neri, P; Prabhala, R; Shammas, MA; Tai, YT; Treon, SP	1
Chen, ZC; Li, QB; Lü, J; Shao, J	1

Other Studies

18 other study(ies) available for catechin and Kahler Disease

Article	Year
(-)-Epigallocatechin-3-gallate plays an antagonistic role in the antitumor effect of bortezomib in myeloma cells via activating Wnt/β-catenin signaling pathway. Advances in clinical and experimental medicine : official organ Wroclaw Medical University, 2022, Volume: 31, Issue:7 Topics: Apoptosis; Bortezomib; Catechin; Cell Line, Tumor; Cell Proliferation; Humans; Multiple Myeloma; Tea; Wnt Signaling Pathway	2022
Targeting Glutaminolysis to Treat Multiple Myeloma: An Anti-cancer agents in medicinal chemistry, 2023, Volume: 23, Issue:7 Topics: Apoptosis; Catechin; Cell Line, Tumor; Cell Proliferation; Glutaminase; Glutamine; Humans; Multiple Myeloma; Proto-Oncogene Proteins c-bcl-2	2023
The anti-cancer effect of epigallocatechin-3-O-gallate against multiple myeloma cells is potentiated by 5,7-dimethoxyflavone. FEBS open bio, 2023, Volume: 13, Issue:11 Topics: Apoptosis; Catechin; Cell Line, Tumor; Humans; Multiple Myeloma	2023
Epigallocatechin-3-O-gallate induces acid sphingomyelinase activation through activation of phospholipase C. Biochemical and biophysical research communications, 2019, 11-26, Volume: 520, Issue:1 Topics: Apoptosis; Catechin; Cell Line, Tumor; Cyclic GMP; Enzyme Activation; Gene Expression Regulation, Neoplastic; Humans; Multiple Myeloma; Phosphorylation; Signal Transduction; Sphingomyelin Phosphodiesterase; Type C Phospholipases	2019
Cancer cell selective probe by mimicking EGCG. Biochemical and biophysical research communications, 2020, 05-14, Volume: 525, Issue:4 Topics: Animals; Anticarcinogenic Agents; Antioxidants; Catechin; Cell Line, Tumor; Fluorescence; Gene Knockdown Techniques; Humans; Mice; Multiple Myeloma; Protein Binding; Proto-Oncogene Proteins c-akt; Receptors, Laminin; Signal Transduction	2020
Epigallocatechin gallate inhibits the proliferation and induces apoptosis of multiple myeloma cells via inactivating EZH2. European review for medical and pharmacological sciences, 2018, Volume: 22, Issue:7 Topics: Apoptosis; Catechin; Cell Line, Tumor; Cell Proliferation; Enhancer of Zeste Homolog 2 Protein; Humans; Mitochondria; Multiple Myeloma; Proto-Oncogene Proteins c-bcl-2; Tea	2018
Regulation of p53-targeting microRNAs by polycyclic aromatic hydrocarbons: Implications in the etiology of multiple myeloma. Molecular carcinogenesis, 2015, Volume: 54, Issue:10 Topics: 3' Untranslated Regions; Benzo(a)pyrene; Carcinogens, Environmental; Catechin; Cell Line, Tumor; Cell Survival; Down-Regulation; HeLa Cells; Humans; MicroRNAs; Multiple Myeloma; Polycyclic Aromatic Hydrocarbons; Promoter Regions, Genetic; Receptors, Aryl Hydrocarbon; Tumor Suppressor Protein p53; Up-Regulation	2015
Sphingosine Kinase-1 Protects Multiple Myeloma from Apoptosis Driven by Cancer-Specific Inhibition of RTKs. Molecular cancer therapeutics, 2015, Volume: 14, Issue:10 Topics: Animals; Antineoplastic Agents; Apoptosis; Catechin; Cell Line, Tumor; Death-Associated Protein Kinases; Drug Synergism; Enzyme Activation; Female; Humans; Membrane Microdomains; Mice, Inbred BALB C; Multiple Myeloma; Phosphotransferases (Alcohol Group Acceptor); Receptor Protein-Tyrosine Kinases; Signal Transduction; Sphingomyelin Phosphodiesterase; Sphingosine; Xenograft Model Antitumor Assays	2015
Potentiation of (-)-epigallocatechin-3-gallate-induced apoptosis by bortezomib in multiple myeloma cells. Acta biochimica et biophysica Sinica, 2009, Volume: 41, Issue:12 Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Boronic Acids; Bortezomib; Catechin; Cell Line, Tumor; Humans; Multiple Myeloma; Polymerase Chain Reaction; Pyrazines; RNA, Messenger; Tea; Transcription Factor RelA	2009
Green tea polyphenol EGCG induces lipid-raft clustering and apoptotic cell death by activating protein kinase Cδ and acid sphingomyelinase through a 67 kDa laminin receptor in multiple myeloma cells. The Biochemical journal, 2012, Apr-15, Volume: 443, Issue:2 Topics: Animals; Apoptosis; Caspase 3; Catechin; Cell Line, Tumor; Enzyme Activation; Humans; Membrane Microdomains; Mice; Molecular Weight; Multiple Myeloma; Protein Kinase C-delta; Receptors, Laminin; Sphingomyelin Phosphodiesterase; Tea	2012
The role of peroxiredoxin V in (-)-epigallocatechin 3-gallate-induced multiple myeloma cell death. Oncology research, 2011, Volume: 19, Issue:8-9 Topics: Acetylcysteine; Apoptosis; Catechin; Cell Line, Tumor; Cell Survival; Extracellular Signal-Regulated MAP Kinases; Humans; JNK Mitogen-Activated Protein Kinases; Multiple Myeloma; p38 Mitogen-Activated Protein Kinases; Peroxiredoxins; Phosphorylation; Plasma Cells; Reactive Oxygen Species; Signal Transduction; Syndecan-1	2011
67-kDa laminin receptor increases cGMP to induce cancer-selective apoptosis. The Journal of clinical investigation, 2013, Volume: 123, Issue:2 Topics: Animals; Apoptosis; Caspases; Catechin; Cell Line, Tumor; Cell Proliferation; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Female; Humans; Imidazoles; Male; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Molecular Weight; Multiple Myeloma; Neoplasms; Phosphodiesterase 5 Inhibitors; Piperazines; Receptors, Laminin; Signal Transduction; Sulfones; Triazines; Vardenafil Dihydrochloride; Xenograft Model Antitumor Assays	2013
Mechanisms involved in the differential bone marrow homing of CD45 subsets in 5T murine models of myeloma. Clinical & experimental metastasis, 2002, Volume: 19, Issue:7 Topics: Animals; Bone Marrow; Catechin; Cell Adhesion; Cells, Cultured; Chemotaxis; Endothelium; Fibroblasts; Laminin; Leukocyte Common Antigens; Male; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred C57BL; Multiple Myeloma; Neoplasm Invasiveness; Neoplasms, Experimental; Protease Inhibitors; Receptors, Cell Surface; Receptors, Urokinase Plasminogen Activator; T-Lymphocyte Subsets; Urokinase-Type Plasminogen Activator	2002
Membrane-rigidifying effects of anti-cancer dietary factors. BioFactors (Oxford, England), 2002, Volume: 16, Issue:3-4 Topics: Animals; Antineoplastic Agents, Phytogenic; Apigenin; Catechin; Cell Division; Cell Membrane; Diet; Flavonoids; Fluorescence Polarization; Genistein; Isoflavones; Liposomes; Membrane Fluidity; Membrane Lipids; Mice; Multiple Myeloma; Phenols; Resveratrol; Stilbenes; Tumor Cells, Cultured	2002
Study of the combined effect of X-irradiation and epigallocatechin-gallate (a tea component) on the growth inhibition and induction of apoptosis in human cancer cell lines. Oncology reports, 2004, Volume: 12, Issue:1 Topics: Anticarcinogenic Agents; Apoptosis; Catechin; Cell Cycle; Cell Division; Cell Line, Tumor; Cell Survival; HeLa Cells; Humans; K562 Cells; Multiple Myeloma; X-Rays	2004
Green tea component, catechin, induces apoptosis of human malignant B cells via production of reactive oxygen species. Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Aug-15, Volume: 11, Issue:16 Topics: Apoptosis; Arsenic Trioxide; Arsenicals; B-Lymphocytes; bcl-2-Associated X Protein; Caspase 3; Caspases; Catechin; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Intracellular Membranes; Membrane Potentials; Mitochondria; Multiple Myeloma; Oxides; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Signal Transduction; Tea; Time Factors	2005
Specific killing of multiple myeloma cells by (-)-epigallocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implications. Blood, 2006, Oct-15, Volume: 108, Issue:8 Topics: Animals; Antineoplastic Agents; Apoptosis; Catechin; Cell Line, Tumor; Gene Expression Profiling; Humans; Mice; Mice, SCID; Multiple Myeloma; Neoplasm Transplantation; Phytotherapy; Receptors, Laminin; RNA, Small Interfering; Tea; Transplantation, Heterologous	2006
[Inhibitory Effect of EGCG on angiogenesis induced by multiple myeloma cell line KM3 and its mechanism]. Zhongguo shi yan xue ye xue za zhi, 2007, Volume: 15, Issue:5 Topics: Angiogenesis Inhibitors; Catechin; Cell Line, Tumor; Down-Regulation; Humans; Multiple Myeloma; RNA, Messenger; Vascular Endothelial Growth Factor A	2007